Literature DB >> 12850492

The global distribution of length polymorphisms of the promoters of the glucuronosyltransferase 1 gene (UGT1A1): hematologic and evolutionary implications.

A Premawardhena1, C A Fisher, Y T Liu, I C Verma, S de Silva, M Arambepola, J B Clegg, D J Weatherall.   

Abstract

The promoter region of the UDP glucuronosyltransferase 1 gene (UGT1A1) contains a run of thymine-adenine (TA) repeats, usually six (TA)(6). As well as its relationship to Gilbert's syndrome, homozygosity for the extended sequence, (TA)(7) (TA)(7), has been found to be an important risk factor for hyperbilirubinemia and gallstones in patients with hemoglobin E-beta-thalassemia and other intermediate forms of beta thalassemia. To assess the importance of this polymorphism in these common disorders a wide-scale population study of the relative frequency of the size alleles of the UGT1A1 promoter has been carried out. Homozygosity for the (TA)(7) allele occurs in 10-25% of the populations of Africa and the Indian subcontinent, with a variable frequency in Europe. It occurs at a much lower frequency in Southeast Asia, Melanesia, and the Pacific Islands, ranging from 0 to 5%. African populations show a much greater diversity of length alleles than other populations. These findings define those populations with a high frequency of hemoglobin E-beta-thalassemia and related disorders that are at increased risk for hyperbilirubinemia and gall bladder disease and provide evolutionary insights into how these polymorphisms have arisen and are so unequally distributed among human populations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12850492     DOI: 10.1016/s1079-9796(03)00071-8

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  35 in total

1.  Glucuronidation of OTS167 in Humans Is Catalyzed by UDP-Glucuronosyltransferases UGT1A1, UGT1A3, UGT1A8, and UGT1A10.

Authors:  Jacqueline Ramírez; Snezana Mirkov; Larry K House; Mark J Ratain
Journal:  Drug Metab Dispos       Date:  2015-04-13       Impact factor: 3.922

Review 2.  The role of pharmacogenetics in cancer therapeutics.

Authors:  Wei Peng Yong; Federico Innocenti; Mark J Ratain
Journal:  Br J Clin Pharmacol       Date:  2006-07       Impact factor: 4.335

Review 3.  Therapeutic drug monitoring and pharmacogenetic tests as tools in pharmacovigilance.

Authors:  Eveline Jaquenoud Sirot; Jan Willem van der Velden; Katharina Rentsch; Chin B Eap; Pierre Baumann
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

4.  The effect of UGT1A1 promoter polymorphism in the development of hyperbilirubinemia and cholelithiasis in hemoglobinopathy patients.

Authors:  Suad AlFadhli; Hassan Al-Jafer; Mays Hadi; Mashael Al-Mutairi; Rasheeba Nizam
Journal:  PLoS One       Date:  2013-10-30       Impact factor: 3.240

5.  Is there diversity among UGT1A1 polymorphism in Japan?

Authors:  Michiya Kobayashi; Shoichi Hazama; Kenichi Takahashi; Koji Oba; Naoko Okayama; Mitsuaki Nishioka; Yuji Hinoda; Masaaki Oka; Ken Okamoto; Hiromichi Maeda; Daisuke Nakamura; Junichi Sakamoto; Hideyuki Mishima
Journal:  World J Gastrointest Oncol       Date:  2012-07-15

6.  Obstetric Obesity is Associated with Neonatal Hyperbilirubinemia with High Prevalence in Native Hawaiians and Pacific Island Women.

Authors:  Luc Ra Rougée; Shogo J Miyagi; Abby C Collier
Journal:  Hawaii J Med Public Health       Date:  2016-12

7.  Serum bilirubin links UGT1A1*28 polymorphism and predicts long-term cardiovascular events and mortality in chronic hemodialysis patients.

Authors:  Ying-Hwa Chen; Szu-Chun Hung; Der-Cherng Tarng
Journal:  Clin J Am Soc Nephrol       Date:  2011-03       Impact factor: 8.237

Review 8.  The hemoglobin E thalassemias.

Authors:  Suthat Fucharoen; David J Weatherall
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

9.  Association between inherited monogenic liver disorders and chronic hepatitis C.

Authors:  Linda Piekuse; Madara Kreile; Agnese Zarina; Zane Steinberga; Valentina Sondore; Jazeps Keiss; Baiba Lace; Astrida Krumina
Journal:  World J Hepatol       Date:  2014-02-27

10.  UGT1A1 gene variants and clinical risk factors modulate hyperbilirubinemia risk in newborns.

Authors:  P K Tiwari; A Bhutada; R Agarwal; S Basu; R Raman; A Kumar
Journal:  J Perinatol       Date:  2013-11-14       Impact factor: 2.521

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.